Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
6.95
+0.12 (1.76%)
At close: Mar 6, 2026, 4:00 PM EST
6.57
-0.38 (-5.54%)
After-hours: Mar 6, 2026, 5:15 PM EST
Kezar Life Sciences Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Kezar Life Sciences stock have an average target of 6.00, with a low estimate of 5.00 and a high estimate of 7.00. The average target predicts a decrease of -13.67% from the current stock price of 6.95.
Analyst Consensus: Hold
* Price targets were last updated on Oct 17, 2025.
Analyst Ratings
The average analyst rating for Kezar Life Sciences stock from 4 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $18 → $7 | Strong Buy → Hold | Downgrades | $18 → $7 | +0.72% | Oct 17, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 17, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | -28.06% | Oct 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jul 16, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $11 → $9 | Hold | Maintains | $11 → $9 | +29.50% | Dec 19, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-6.95
from -11.49
EPS Next Year
-3.50
from -6.95
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -6.57 | -0.95 | ||||
| Avg | -6.95 | -3.50 | ||||
| Low | -7.09 | -4.93 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.